DCIDS Tissue Bank has strict donor screening and eligibility criteria to minimize the risk of disease transmission. The initial screening involves getting and reviewing an exhaustive social and medical history of the donor. To further enhance the safety, Serum samples obtained from the donor are tested by a CLIA (clinical laboratory improvement amendment of 1988) certified laboratory for the following.
- HIV-I & II Antibodies
- Hepatitis B surface antigen
- Hepatitis B core total antibody
- Hepatitis C antibody
- HIV-I and HCV Nucleic Acid Test by Transcription Mediated Amplification
Tissue is processed when all the test results are negative. Terminal gamma irradiation ensures the sterility of the grafts released for implantation. In the case of non irradiated tissue, final release is contingent upon negative results from microbiological testing.